Back
Aligos Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
61
ALGS
Aligos Therapeutics, Inc.
Last Price:
$10.11
Seasonality Move:
-27.85%
7 Day Trial
ALL ACCESS PASS
$
7
Aligos Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Aligos Therapeutics, Inc. has on average historically fallen by 26% based on the past 5 years of stock performance.
-
Aligos Therapeutics, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
-
Is Aligos Therapeutics, Inc. Stock Undervalued?The current Aligos Therapeutics, Inc. [ALGS] share price is $10.11. The Score for ALGS is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Aligos Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Aligos Therapeutics, Inc. has on average historically fallen by 26% based on the past 5 years of stock performance.
Aligos Therapeutics, Inc. Stock Rating
Buy
61
Aligos Therapeutics, Inc. (ALGS)
is a Buy
Is Aligos Therapeutics, Inc. overpriced?
-
Aligos Therapeutics, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Aligos Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
aligos.com
52-Week Data
52-Week High:
46.80
52-Week Low:
3.76
Prediction Charts
Market Cap:
62.2M
Price in USD:
10.11
Volume:
29.6K
Beta:
2.75
Technical Analysis
SMA50:
9.32
SMA100:
9.50
SMA200:
8.35
52-Wk Change:
-76.69%
Stock Predictions
-
Is Aligos Therapeutics, Inc. stock public?Yes, Aligos Therapeutics, Inc. is a publicly traded company.
-
What is the Aligos Therapeutics, Inc. stock quote today?The Aligos Therapeutics, Inc. stock price is 10.11 USD today.
-
How to buy Aligos Therapeutics, Inc. stock online?You can buy Aligos Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-5 | 10.12 | 9.99 | 10.26 | 9.84 |
| Dec-8 | 10.17 | 10.78 | 10.84 | 10.08 |
| Dec-9 | 10.73 | 11.08 | 11.17 | 10.49 |
| Dec-10 | 11.08 | 11.33 | 11.50 | 10.65 |
| Dec-11 | 11.30 | 11.51 | 11.63 | 11.20 |
| Dec-12 | 11.61 | 13.30 | 13.68 | 11.44 |
| Dec-15 | 13.43 | 12.00 | 13.69 | 11.45 |
| Dec-16 | 11.92 | 11.47 | 12.10 | 11.04 |
| Dec-17 | 11.73 | 10.63 | 11.91 | 10.45 |
| Dec-18 | 10.75 | 10.37 | 11.00 | 10.19 |
| Dec-19 | 10.32 | 10.68 | 11.04 | 10.32 |
| Dec-22 | 10.64 | 10.75 | 11.50 | 10.10 |
| Dec-24 | 9.95 | 10.52 | 10.69 | 9.81 |
| Dec-26 | 10.34 | 10.11 | 10.50 | 9.85 |
Aligos Therapeutics, Inc. Earnings
Aligos Therapeutics, Inc. Earnings Report: Per Share Aligos Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Aligos Therapeutics, Inc. Forecast Revenue Growth
Aligos Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Aligos Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.41 per share, and a decrease next year of $0.26 per share.
* Aligos Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.